1. The Ontario Uterine Fibroid Embolization Trial. Part 2
The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids 
Gaylene Pron, Ph.D., John Bennett, M.D., Andrew Common, M.D., Jane Wall, M.D., Murray Asch, M.D., Kenneth Sniderman, M.D., 
Fertility and Sterility 
Volume 79, Issue 1, Pages (January 2003)
DOI: /S (02)

2. FIGURE 1
Fibroid UAE effects on menstrual duration. Mean duration menstrual flow: pre-UAE = 7.6 days; 3 months post-UAE = 5.4 days (P<.001).
Pron. Fibroid uterine artery embolization effectiveness. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (02) )

3. FIGURE 2
Fibroid symptom life-impact scores pre- and post-UAE. Median fibroid symptom life-impact score: pre-UAE = 8.0; 3 months post-UAE = 3.0 (P<.001).
Pron. Fibroid uterine artery embolization effectiveness. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (02) )

4. FIGURE 3
Relationship of patient satisfaction with UAE treatment to changes in their fibroid symptom life-impact score after UAE.
Pron. Fibroid uterine artery embolization effectiveness. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (02) )